Surgical treatment of type 2 diabetes: The surgeon perspective

Endocrine

Volumn 40, Issue 2, 2011, Pages 151-161

  Shukla, Alpana P ^a   Ahn, Soo Min ^a   Patel, Rajesh T ^a   Rosenbaum, Matthew W ^a   Rubino, Francesco ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cost effectiveness; Efficacy; Metabolic surgery; Safety; Type 2 diabetes mellitus (T2DM)

Indexed keywords

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CARDIOVASCULAR RISK; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE COURSE; DYSLIPIDEMIA; EXPERIMENTAL STUDY; GASTRIC BANDING; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTESTINE BYPASS; JEJUNOILEAL BYPASS; LONG TERM SURVIVAL; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REMISSION; REVIEW; ROUX Y ANASTOMOSIS; SAFETY; SLEEVE GASTRECTOMY;

EID: 84855230158     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9508-8     Document Type: Review

References (84)

1. R.A. Defronzo, Banting lecture: from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4), 773-795 (2009)
2. R.C. Turner, The UK prospective diabetes study: a review. Diabetes Care 21(Suppl 3), C35-C38 (1998)
3. S. Zoungas, B.E. de Galan, T. Ninomiya, D. Grobbee, P. Hamet, S. Heller, S. MacMahon, M. Marre, B. Neal, A. Patel, M. Woodward, J. Chalmers, ADVANCE Collaborative Group, A. Cass, P. Glasziou, S. Harrap, L. Lisheng, G. Mancia, A. Pillai, N. Poulter, V. Perkovic, F. Travert, Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care 32(11), 2068-2074 (2009)
4. H. Buchwald, Y. Avidor, E. Braunwald, M.D. Jensen, W. Pories, K. Fahrbach, K. Schoelles, Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14), 1724-1737 (2004) (Pubitemid 39346675)
5. D. Pacheco, D.A. de Luis, A. Romero, The effects of duodenaljejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am. J. Surg. 194, 221-224 (2007) (Pubitemid 47008973)
6. F. Rubino, A. Forgione, D.E. Cummings, M. Vix, D. Gnuli, G. Mingrone, M. Castagneto, J. Marescaux, The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann. Surg. 244, 741-749 (2006) (Pubitemid 44629948)
7. P.E. O'Brien, J.B. Dixon, C. Laurie, Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann. Intern. Med. 144, 625-633 (2006) (Pubitemid 46780646)
8. 2: a tailored approach. Surg. Obes. Relat. Dis. 2, 401-404 (2006) (Pubitemid 43812096)
9. 2. J. Gastrointest. Surg. 12, 945-952 (2008)
10. N. Scopinaro, G.M. Marinari, G. Camerini, Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes. Surg. 12(2), 241-244 (2002) (Pubitemid 34442086)
11. F. Rubino, J. Marescaux, Effect of duodenal-jejunal exclusion in a nonobese animal model of type 2 diabetes: a new perspective for an old disease. Ann. Surg. 239, 1-11 (2004) (Pubitemid 38176365)
12. 2. Surg. Obes. Relat. Dis. 3, 195-197 (2007) (Pubitemid 46444706)
13. 2. Obes. Surg. 19, 307-312 (2009)
14. F. Rubino, P.R. Schauer, L.M. Kaplan, D.E. Cummings, Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu. Rev. Med. 61, 393-411 (2010)
15. H.S. Koopmans, A. Sclafani, C. Fichtner, P.F. Aravich, The effects of ileal transposition on food intake and body weight loss in VMH-obese rats. Am. J. Clin. Nutr. 35(2), 284-293 (1982) (Pubitemid 12121027)
16. A.L. de Paula, A.L. Macedo, A.S. Prudente, L. Queiroz, V. Schraibman, J. Pinus, Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine brake")-pilot study of a new operation. Surg. Obes. Relat. Dis 2, 464-466 (2006)
17. W.J. Pories, M.S. Swanson, K.G. MacDonald, S.B. Long, P.G. Morris, B.M. Brown, H.A. Barakat, R.A. de Ramon, G. Israel, J.M. Doleza et al., Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann. Surg. 222, 339-350 (1995)
18. P.R. Schauer, B. Burguera, S. Ikramuddin, D. Cottam, W. Gourash, G. Hamad, G.M. Eid, S. Mattar, R. Ramanathan, E. Barinas-Mitchel, R.H. Rao, L. Kuller, D. Kelley, Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann. Surg. 238, 467-484 (2003)
19. C.D. Sjöström, L. Lissner, H. Wedel, L. Sjöström, Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes. Res. 7(5), 477-484 (1999) (Pubitemid 129710611)
20. R.S. Gill, D.W. Birch, X. Shi, A.M. Sharma, S. Karmali, Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 6(6), 707-713 (2010)
21. L. Angervall, G. Dotevall, H. Tillander, Amelioration of diabetes mellitus following gastric resection. Acta Med. Scand. 169, 743-748 (1961)
22. S. Forgacs, T. Halmos, Improvement of glucose tolerance in diabetics following gastrectomy. Z. Gastroenterol. 11, 293-296 (1973)
23. J.B. Dixon, P.E. O'Brien, J. Playfair, Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 299, 316-323 (2008) (Pubitemid 351159368)
24. 2. Diabetologia 52, 1027-1030 (2009)
25. N. Scopinaro, G.F. Adami, F.S. Papadia, G. Camerini, F. Carlini, M. Fried, L. Briatore, G. D'alessandro, G. Andraghetti, R. Cordera, Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann. Surg. 253(4), 699-703 (2011)
26. H.C. Lee, M.K. Kim, H.S. Kwon, Early change in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes. Surg. 20, 1530-1535 (2010)
27. J.A. Tice, L. Karliner, J. Walsh, A.J. Petersen, M.D. Feldman, Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am. J. Med. 121(10), 885-893 (2008)
28. D.R. Cottam, J. Atkinson, A. Anderson, B. Grace, B. Fisher, A case-controlled matched-pair cohort study of laparoscopic Rouxen-Y gastric bypass and Lap-Band patients in a single US center with three-year follow-up. Obes. Surg. 16(5), 534-540 (2006) (Pubitemid 43781035)
29. G.M. Campos, C. Rabl, G.R. Roll, S. Peeva, K. Prado, J. Smith, E. Vittinghoff, Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study. Arch. Surg. 146(2), 149-155 (2011)
30. W.J. Lee, K. Chong, K.H. Ser, Y.C. Lee, S.C. Chen, J.C. Chen, M.H. Tsai, L.M. Chuang, Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch. Surg. 146(2), 143-148 (2011)
31. J.P. Thaler, D.E. Cummings, Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150(6), 2518-2525 (2009)
32. B. Laferrère, J. Teixeira, J. McGinty, H. Tran, J.R. Egger, A. Colarusso, B. Kovack, B. Bawa, N. Koshy, H. Lee, K. Yapp, B. Olivan, Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 93, 2479-2485 (2008) (Pubitemid 352008510)
33. F. Pattou, G. Beraud, L. Arnalsteen, D. Seguy, P. Pigny, C. Fermont, M. Romon, P. Fontaine, Restoration of beta cell function after bariatric surgery in type 2 diabetic patients: a prospective controlled study comparing gastric banding and gastric bypass. Obes. Surg. 17, 1041-1042 (2007)
34. J. Korner, W. Inabnet, G. Febres, I.M. Conwell, D.J. McMahon, R. Salas, C. Taveras, B. Schrope, M. Bessler, Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int. J. Obes. (Lond.) 33(7), 786-795 (2009)
35. F. Pattou, G. Beraud, L. Arnalsteen et al., Catering of insulin secretion after a gastric bypass in type 2 diabetics is independent from weight loss and correlated to the increase of GLP1. Diabetes Metab. 34, 23 (2008)
36. K. Meirelles, T. Ahmed, D.M. Culnan, C.J. Lynch, C.H. Lang, R.N. Cooney, Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann. Surg. 249, 277-285 (2009)
37. A.E. Pontiroli, P. Pizzocri, M.C. Librenti, P. Vedani, M. Marchi, E. Cucchi, C. Orena, M. Paganelli, M. Giacomelli, G. Ferla, F. Folli, Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J. Clin. Endocrinol. Metab. 87, 3555-3561 (2002) (Pubitemid 34879496)
38. F. Rubino, P. Zizzari, C. Tomasetto, M.T. Bluet-Pajot, A. Forgione, M. Vix, D. Grouselle, J. Marescaux, The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology 146, 1745-1751 (2005) (Pubitemid 40396883)
39. V. Aguirre, N. Stylopoulos, R. Grinbaum, L.M. Kaplan, An endoluminal sleeve induces substantial weight Loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) 16, 2585-2592 (2008)
40. M. Tarnoff, L. Rodriguez, A. Escalona, A. Ramos, M. Neto, M. Alamo, E. Reyes, F. Pimentel, L. Ibanez, Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for preoperative weight loss in bariatric surgery. Surg. Endosc. 23, 650-656 (2009)
41. L. Rodriguez, E. Reyes, P. Fagalde, M.S. Oltra, J. Saba, C.G. Aylwin, C. Prieto, A. Ramos, M. Galvao, K.S. Gersin, C. Sorli, Pilot clinical study of an endoscopic, removable duodenaljejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol. Therap. 11(11), 725-732 (2009)
42. H.S. Koopmans, G.L. Ferri, D.L. Sarson, J.M. Polak, S.R. Bloom, The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats. Physiol. Behav. 33, 601-609 (1984) (Pubitemid 15201821)
43. A. Patriti, M.C. Aisa, C. Annetti, A. Sidoni, F. Galli, I. Ferri, N. Gullà, A. Donini, How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-Kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery 142, 74-85 (2007) (Pubitemid 47042093)
44. J.P. Bantle, S. Ikramuddin, T.A. Kellogg, H. Buchwald, Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes. Surg. 17, 592-594 (2007) (Pubitemid 46945415)
45. M.E. Patti, G. McMahon, E.C. Mun, A. Bitton, J.J. Holst, J. Goldsmith, D.W. Hanto, M. Callery, R. Arky, V. Nose, S. Bonner-Weir, A.B. Goldfine, Severe hypoglycaemia postgastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48, 2236-2240 (2005) (Pubitemid 41618912)
46. E.V. Polyzogopoulou, F. Kalfarentzos, A.G. Vagenakis, T.K. Alexandrides, Restoration of euglycemia and Normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 52, 1098-1103 (2003) (Pubitemid 36523342)
47. B. Laferrère, S. Heshka, K. Wang, Y. Khan, J. McGinty, J. Teixeira, A.B. Hart, B. Olivan, Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30, 1709-1716 (2007) (Pubitemid 47036341)
48. D.E. Cummings, J. Overduin, K.E. Foster-Schubert, Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J. Clin. Endocrinol. Metab. 89, 2608-2615 (2004) (Pubitemid 38766339)
49. R. Lugari, A. Dei Cas, D. Ugolotti, A.L. Barilli, C. Camellini, G.C. Ganzerla, A. Luciani, B. Salerni, F. Mittenperger, S. Nodari, A. Gnudi, R. Zandomeneghi, Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Horm. Metab. Res. 36(2), 111-115 (2004) (Pubitemid 38392252)
50. J.P. Valderas, V. Irribarra, C. Boza, R. de la Cruz, Y. Liberona, A.M. Acosta, M. Yolito, A. Maiz, Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss. J. Clin. Endocrinol. Metab. 95(3), 1069-1075 (2010)
51. R. Peterli, B. Wölnerhanssen, T. Peters, N. Devaux, B. Kern, C. Christoffel-Courtin, J. Drewe, M. von Flüe, C. Beglinger, Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann. Surg. 250(2), 234-241 (2009)
52. A.L. DePaula, A.L. Macedo, N. Rassi, C.A. Machado, V. Schraibman, L.Q. Silva, A. Halpern, Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg. Endosc. 22, 706-716 (2008) (Pubitemid 351341683)
53. D.E. Cummings, D.S. Weigle, R.S. Frayo, P.A. Breen, M.K. Ma, E.P. Dellinger, J.Q. Purnell, Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. N. Engl. J. Med. 346, 1623-1630 (2002) (Pubitemid 34755670)
54. D.E. Cummings, M.H. Shannon, Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J. Clin. Endocrinol. Metab. 88, 2999-3002 (2003) (Pubitemid 36877461)
55. J. Ybarra, E. Bobbioni-Harsch, G. Chassot, O. Huber, P. Morel, F. Assimacopoulos-Jeannet, A. Golay, Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss. Obes. Surg. 19(3), 327-331 (2009)
56. M.E. Couce, D. Cottam, J. Esplen, P. Schauer, B. Burguera, Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes. Surg. 16(7), 870-878 (2006) (Pubitemid 44133475)
57. F. Rubino, Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 31(Suppl. 2), S290-S296 (2008)
58. E.J. DeMaria, V. Pate, M. Warthen, D.A. Winegar, Baseline data from American Society for Metabolic and Bariatric Surgerydesignated Bariatric Surgery Centers of Excellence using the bariatric outcomes longitudinal database. Surg Obes Relat Dis. 6(4), 347-355 (2010)
59. H. Buchwald, R. Estok, K. Fahrbach, D. Banel, I. Sledge, Trends in mortality in bariatric surgery: a systematic review and metaanalysis. Surgery 142(4), 621-635 (2007) (Pubitemid 47575601)
60. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, D.R. Flum, S.H. Belle, W.C. King, A.S. Wahed, P. Berk, W. Chapman, W. Pories, A. Courcoulas, C. McCloskey, J. Mitchell, E. Patterson, A. Pomp, M.A. Staten, S.Z. Yanovski, R. Thirlby, B. Wolfe, Perioperative safety in the longitudinal assessment of bariatric surgery. N. Engl. J. Med. 361, 445-454 (2009)
61. 2: an integrative review of early studies. Obes. Surg. 20(6), 776-790 (2010)
62. W.E. Encinosa, D.M. Bernard, D. Du, C.A. Steiner, Recent improvements in bariatric surgery outcomes. Med. Care 47, 531-535 (2009)
63. N.T. Nguyen, M. Hinojosa, C. Fayad, E. Varela, S.E. Wilson, Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J. Am. Coll. Surg. 205, 248-255 (2007) (Pubitemid 47095420)
64. R.E. Brolin, L.B. LaMarca, H.A. Kenler, R.P. Cody, Malabsorptive gastric bypass in patients with superobesity. J. Gastrointest. Surg. 6, 195-205 (2002) (Pubitemid 40433572)
65. R.D. Bloomberg, A. Fleishman, J.E. Nalle, D.M. Herron, S. Kini, Nutritional deficiencies following bariatric surgery: what have we learned? Obes. Surg. 15, 145-154 (2005) (Pubitemid 40315996)
66. R.E. Brolin, R.C. Gorman, L.M. Milgrim, H.A. Kenler, Multivitamin prophylaxis in prevention of postgastric bypass vitamin and mineral deficiencies. Int. J. Obes. 15, 661-667 (1991)
67. J.D. Halverson, Micronutrient deficiencies after gastric bypass for morbid obesity. Am. Surg. 52, 594-598 (1986) (Pubitemid 17181161)
68. G.H. Slater, C.J. Ren, N. Siegel, T. Williams, D. Barr, B. Wolfe, K. Dolan, G.A. Fielding, Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J. Gastrointest. Surg. 8(1), 48-55 (2004) (Pubitemid 38117277)
69. L. Sjöström, A.K. Lindroos, M. Peltonen, J. Torgerson, C. Bouchard, B. Carlsson, S. Dahlgren, B. Larsson, K. Narbro, C.D. Sjöström, M. Sullivan, H. Wedel, Swedish Obese Subjects Study Scientific Group, Swedish Obese Subjects Study Scientific Group Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 23 351(26), 2683-2693 (2004)
70. T.D. Adams, R.E. Gress, S.C. Smith, R.C. Halverson, S.C. Simper, W.D. Rosamond, M.J. Lamonte, A.M. Stroup, S.C. Hunt, Long-term mortality after gastric bypass surgery. N. Engl. J. Med. 357, 753-761 (2007) (Pubitemid 47295642)
71. L. Busetto, D. Mirabelli, M.L. Petroni, M. Mazza, F. Favretti, G. Segato, M. Chiusolo, F. Merletti, F. Balzola, G. Enzi, Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 3(5), 496-502 (2007) (Pubitemid 47454437)
72. T.J. Hoerger, P. Zhang, J.E. Segel, H.S. Kahn, L.E. Barker, S. Couper, Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care 33(9), 1933-1939 (2010)
73. C.L. Keating, J.B. Dixon, M.L. Moodie, A. Peeters, L. Bulfone, D.J. Maglianno, P.E. O'Brien, Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care 32(4), 567-574 (2009)
74. R. Ackroyd, J. Mouiel, J.M. Chevallier, F. Daoud, Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes. Surg. 16(11), 1488-1503 (2006) (Pubitemid 44759983)
75. M. Anselmino, T. Bammer, J.M. Fernández Cebrián, F. Daoud, G. Romagnoli, A. Torres, Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries(II). Obes. Surg. 19(11), 1542-1549 (2009)
76. D. Benaiges, A. Goday, J.M. Ramon, E. Hernandez, M. Pera, J.F. Cano, Obemar Group, Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg. Obes. Relat. Dis. (2011) [Epub ahead of print]
77. M.A. Lakdawala, A. Bhasker, D. Mulchandani, S. Goel, S. Jain, Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes. Surg. 20(1), 1-6 (2010)
78. N. Hamza, M.H. Abbas, A. Darwish, Z. Shafeek, J. New, B.J. Ammori, Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg. Obes. Relat. Dis. (2010) [Epub ahead of print]
79. T.C. Hall, M.G. Pellen, P.C. Sedman, P.K. Jain, Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes. Surg. 20(9), 1245-1250 (2010)
80. W.J. Lee, K.H. Ser, K. Chong, Y.C. Lee, S.C. Chen, J.J. Tsou, J.C. Chen, C.M. Chen, Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 147(5), 664-669 (2010)
81. F. Rubino, L.M. Kaplan, P.R. Schauer, D.E. Cummings, Diabetes Surgery Summit Delegates, The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann. Surg. 251(3), 399-405 (2010)
82. J.B. Dixon, P. Zimmet, K.G. Alberti, F. Rubino, on behalf of the International Diabetes Federation Taskforce on Epidemiology, Prevention, Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet. Med. 28(6), 628-642 (2011). doi:10.1111/ j.1464-5491.2011.03306.x
83. S.R. Kashyap, D.L. Bhatt, P.R. Schauer, STAMPEDE Investigators, Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the surgical therapy and medications potentially eradicate diabetes efficiently trial (STAMPEDE). Diabetes Obes. Metab. 12(5), 452-454 (2010)
84. http:\\www.clinicaltrials.gov (2011). Accessed 23 May 2011